Welcome to the TRANSEURO consortium website

TRANSEURO is a European research consortium with the principal objective to develop an efficacious and safe treatment methodology for Parkinson’s disease suffering patients using fetal cell based treatments. The consortium has gathered international experts including leading clinicians, scientists, industrial partners, ethicists and patients’ representatives who have joined forces in a new round of experimental work and cell therapy trials in Parkinson's Disease.

TRANSEURO is coordinated by Prof. Roger Barker from the Cambridge University and is funded by the 7th Framework Program of the European Commission, Contract number HEALTH-F5-2010-242003.

1. Transeuro Workshop on ethics, May 31 - June 1 2012, Freiburg, Germany

2. Transeuro/Neurostemcell joint workshop imaging, September 13-14 2012, London, UK